Stem Cell Manufacturing Market by Product (Consumables, Instrument, HSCs, MSCs, iPSCs, ESCs), Application (Research, Clinical (Autologous, Allogenic), Cell & Tissue Banking), End User (Pharma & Biotech, Hospitals, Tissue Bank) - Global Industry Analysis, Share ,Growth ,Regional Outlook And Forecasts, 2021-2027

The global Stem Cell Manufacturing market gathered revenue around USD 10.2 Billion in 2020 and market is set to grow USD 20.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 11% during the prediction period 2021 to 2027. Growing investments in stem cell-based research, rising awareness about the therapeutic potency of stem cell products, and supportive regulatory framework across developing countries are the key factors supporting the growth of the market. Stem cells play an important role in effective disease management as well as specialized research initiatives, such as personalized medicine and genomic testing. Owing to the growing awareness about the therapeutic potency of stem cells and the limited availability of therapeutic treatments for orphan diseases, various public and private stakeholders across the globe are increasingly investing in the development of stem cell-based technologies.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Stem Cell Manufacturing market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Stem Cell Manufacturing market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Stem Cell Manufacturing market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

North America accounted for the largest share of the stem cell manufacturing market in 2020.

In 2020, North America accounted for the largest share of the stem cell manufacturing market, followed by Europe. The large share of the North American regional segment can be attributed to the extensive ongoing stem cell research activities, and the availability of public-private funding and grants to support the clinical evaluation of stem cells for various applications.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Stem Cell Manufacturing Market are:

The major market players include Thermo Fisher Scientific (US), Merck Millipore (Germany), Lonza Group AG (Switzerland), Danaher Corporation (US), Sartorius AG (Germany), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Stemcell Technologies (Canada), Fujifilm Holdings Corporation (Japan), Miltenyi Biotec (Germany), Terumo BCT Inc. (US), Corning Inc. (US), Bio-Techne Corporation (US), Takara Bio Group (Japan), Eppendorf AG (Germany), Getinge (Sweden), Himedia Laboratories (India), Anterogen (South Korea), Cellgenix GMBH (Germany) and Promocell (Germany).

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

By Product

  • Consumables
    • Culture Media
    • Other Consumables
  • Instruments
    • Bioreactors and Incubators
    • Cell Sorters
    • Other Instruments
  • Stem Cell Lines
    • Hematopoietic stem cells (HSC)
    • Mesenchymal stem cells (MSC)
    • Induced Pluripotent Stem cells (iPSC)
    • Embryonic stem cells (ESC)
    • Neural Stem cells (NSC)
    • Multipotent adult progenitor stem cells

By Application

  • Research Applications
    • Life science research
    • Drug discovery and development
  • Clinical Application
    • Allogenic stem cell therapy
    • Autologous stem cell therapy
  • Cell & Tissue Banking Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic institutes, Research laboratories & contract research organizations
  • Hospitals & surgical centres
  • Cell & tissue banks
  • Other End Users

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Chapter 1.    Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.    Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.    Executive Summary

3.1.  Market Snapshot

Chapter 4.    Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.     Raw Material Procurement Analysis

4.3.2.     Sales and Distribution Channel Analysis

4.3.3.     Downstream Buyer Analysis

Chapter 5.    Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.     Market Drivers

5.1.2.     Market Restraints

5.1.3.     Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.     Bargaining power of suppliers

5.2.2.     Bargaining power of buyers

5.2.3.     Threat of substitute

5.2.4.     Threat of new entrants

5.2.5.     Degree of competition

Chapter 6.    Competitive Landscape

6.1.1.     Company Market Share/Positioning Analysis

6.1.2.     Key Strategies Adopted by Players

6.1.3.     Vendor Landscape

6.1.3.1.          List of Suppliers

6.1.3.2.          List of Buyers

Chapter 7.    Global Stem Cell Manufacturing Market, By Product

7.1.  Stem Cell Manufacturing Market, By Product, 2021-2027

7.1.1.     Consumables

7.1.1.1.          Market Revenue and Forecast (2016-2027)

7.1.2.     Instruments

7.1.2.1.          Market Revenue and Forecast (2016-2027)

7.1.3.     Instruments

7.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 8.    Global Stem Cell Manufacturing Market, By Application

8.1.  Stem Cell Manufacturing Market, by Application, 2021-2027

8.1.1.     Research Applications

8.1.1.1.          Market Revenue and Forecast (2016-2027)

8.1.2.     Clinical Application

8.1.2.1.          Market Revenue and Forecast (2016-2027)

8.1.3.     Cell & Tissue Banking Applications

8.1.3.1.          Market Revenue and Forecast (2016-2027)

Chapter 9.    Global Stem Cell Manufacturing Market, By End User

9.1.  Stem Cell Manufacturing Market, by End User, 2021-2027

9.1.1.     Research Applications

9.1.1.1.          Market Revenue and Forecast (2016-2027)

9.1.2.     Academic institutes, Research laboratories & contract research organizations

9.1.2.1.          Market Revenue and Forecast (2016-2027)

9.1.3.     Hospitals & surgical centres

9.1.3.1.          Market Revenue and Forecast (2016-2027)

9.1.4.     Cell & tissue banks

9.1.4.1.          Market Revenue and Forecast (2016-2027)

9.1.5.     Other End Users

9.1.5.1.          Market Revenue and Forecast (2016-2027)

Chapter 10.Global Stem Cell Manufacturing  Market, Regional Estimates and Trend Forecast

10.1.          North America

10.1.1.  Market Revenue and Forecast, By Product (2016-2027)

10.1.2.  Market Revenue and Forecast, by Application (2016-2027)

10.1.3.  Market Revenue and Forecast, by End User (2016-2027)

10.1.4.  U.S.

10.1.4.1.       Market Revenue and Forecast, By Product (2016-2027)

10.1.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.1.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.1.5.  Rest of North America

10.1.5.1.       Market Revenue and Forecast, By Product (2016-2027)

10.1.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.1.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.          Europe

10.2.1.  Market Revenue and Forecast, By Product (2016-2027)

10.2.2.  Market Revenue and Forecast, by Application (2016-2027)

10.2.3.  Market Revenue and Forecast, by End User (2016-2027)

10.2.4.  UK

10.2.4.1.       Market Revenue and Forecast, By Product (2016-2027)

10.2.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.5.  Germany

10.2.5.1.       Market Revenue and Forecast, By Product (2016-2027)

10.2.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.6.  France

10.2.6.1.       Market Revenue and Forecast, By Product (2016-2027)

10.2.6.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.6.3.       Market Revenue and Forecast, by End User (2016-2027)

10.2.7.  Rest of Europe

10.2.7.1.       Market Revenue and Forecast, By Product (2016-2027)

10.2.7.2.       Market Revenue and Forecast, by Application (2016-2027)

10.2.7.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.          APAC

10.3.1.  Market Revenue and Forecast, By Product (2016-2027)

10.3.2.  Market Revenue and Forecast, by Application (2016-2027)

10.3.3.  Market Revenue and Forecast, by End User (2016-2027)

10.3.4.  India

10.3.4.1.       Market Revenue and Forecast, By Product (2016-2027)

10.3.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.5.  China

10.3.5.1.       Market Revenue and Forecast, By Product (2016-2027)

10.3.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.6.  Japan

10.3.6.1.       Market Revenue and Forecast, By Product (2016-2027)

10.3.6.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.6.3.       Market Revenue and Forecast, by End User (2016-2027)

10.3.7.  Rest of APAC

10.3.7.1.       Market Revenue and Forecast, By Product (2016-2027)

10.3.7.2.       Market Revenue and Forecast, by Application (2016-2027)

10.3.7.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.          MEA

10.4.1.  Market Revenue and Forecast, By Product (2016-2027)

10.4.2.  Market Revenue and Forecast, by Application (2016-2027)

10.4.3.  Market Revenue and Forecast, by End User (2016-2027)

10.4.4.  GCC

10.4.4.1.       Market Revenue and Forecast, By Product (2016-2027)

10.4.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.5.  North Africa

10.4.5.1.       Market Revenue and Forecast, By Product (2016-2027)

10.4.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.5.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.6.  South Africa

10.4.6.1.       Market Revenue and Forecast, By Product (2016-2027)

10.4.6.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.6.3.       Market Revenue and Forecast, by End User (2016-2027)

10.4.7.  Rest of MEA

10.4.7.1.       Market Revenue and Forecast, By Product (2016-2027)

10.4.7.2.       Market Revenue and Forecast, by Application (2016-2027)

10.4.7.3.       Market Revenue and Forecast, by End User (2016-2027)

10.5.          Latin America

10.5.1.  Market Revenue and Forecast, By Product (2016-2027)

10.5.2.  Market Revenue and Forecast, by Application (2016-2027)

10.5.3.  Market Revenue and Forecast, by End User (2016-2027)

10.5.4.  Brazil

10.5.4.1.       Market Revenue and Forecast, By Product (2016-2027)

10.5.4.2.       Market Revenue and Forecast, by Application (2016-2027)

10.5.4.3.       Market Revenue and Forecast, by End User (2016-2027)

10.5.5.  Rest of LATAM

10.5.5.1.       Market Revenue and Forecast, By Product (2016-2027)

10.5.5.2.       Market Revenue and Forecast, by Application (2016-2027)

10.5.5.3.       Market Revenue and Forecast, by End User (2016-2027)

Chapter 11.   Company Profiles

11.1.                 Thermo Fisher Scientific

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.                 Merck Millipore

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.                 Lonza Group AG

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.                 Danaher Corporation

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.                 Sartorius AG

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.                 Bio-Rad Laboratories

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.                 Becton

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.                 Dickinson and Company

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.                 Stemcell Technologies

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.              Fujifilm Holdings Corporation

11.10.1.                   Company Overview

11.10.2.                   Product Offerings

11.10.3.                   Financial Performance

11.10.4.                   Recent Initiatives

Chapter 12.   Research Methodology

12.1.                 Primary Research

12.2.                 Secondary Research

12.3.                 Assumptions

Chapter 13.   Appendix

13.1.                 About Us

13.2.                 Glossary of Terms

Proceed To Buy

USD 4500
USD 3900
USD 1900
USD 1200

Customization Offered

  • check-img Cross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers